235 related articles for article (PubMed ID: 6406444)
1. Mode of action of antidepressant drugs.
Sulser F
J Clin Psychiatry; 1983 May; 44(5 Pt 2):14-20. PubMed ID: 6406444
[No Abstract] [Full Text] [Related]
2. Studies of bupropion's mechanism of antidepressant activity.
Ferris RM; Cooper BR; Maxwell RA
J Clin Psychiatry; 1983 May; 44(5 Pt 2):74-8. PubMed ID: 6406468
[TBL] [Abstract][Full Text] [Related]
3. History of antidepressants: successes and failures.
Kelwala S; Stanley M; Gershon S
J Clin Psychiatry; 1983 May; 44(5 Pt 2):40-8. PubMed ID: 6222036
[No Abstract] [Full Text] [Related]
4. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
Ferris RM; Maxwell RA; Cooper BR; Soroko FE
Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
[TBL] [Abstract][Full Text] [Related]
5. The pharmacologic profile of fluoxetine.
Stark P; Fuller RW; Wong DT
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant drugs: effects on beta-adrenergic and serotonineregic receptors.
Frazer A; Lucki I
Adv Biochem Psychopharmacol; 1982; 31():69-90. PubMed ID: 6282067
[No Abstract] [Full Text] [Related]
7. The development of our understanding of the mechanism of action of antidepressant drugs.
Vetulani J
Pol J Pharmacol Pharm; 1991; 43(4):323-38. PubMed ID: 1811223
[No Abstract] [Full Text] [Related]
8. Antidepressant treatments and regulation of norepinephrine-receptor-coupled adenylate cyclase systems in brain.
Sulser F
Adv Biochem Psychopharmacol; 1984; 39():249-61. PubMed ID: 6087628
[No Abstract] [Full Text] [Related]
9. Some effects of the behaviorally active drug, phenitrone, a purported hashish and LSD antagonist, on brain noradrenergic and serotonergic systems.
Spaulding TC; Dewey WL
Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):503-6. PubMed ID: 1153889
[TBL] [Abstract][Full Text] [Related]
10. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
Ferris RM; Beaman OJ
Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
[TBL] [Abstract][Full Text] [Related]
11. Bupropion: a review of its mechanism of antidepressant activity.
Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
[TBL] [Abstract][Full Text] [Related]
12. Studies on the neurochemical basis of action of antidepressant drugs and electroconvulsive treatment.
Vetulani J
Pol J Pharmacol Pharm; 1984; 36(2-3):101-15. PubMed ID: 6089155
[TBL] [Abstract][Full Text] [Related]
13. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
Ressler KJ; Nemeroff CB
Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic mechanisms of action of antidepressants.
Frazer A; Conway P
Psychiatr Clin North Am; 1984 Sep; 7(3):575-86. PubMed ID: 6091070
[TBL] [Abstract][Full Text] [Related]
15. [Antidepressive agents: classification and mechanism of action].
Cuenca E; Alamo C; Coullaut-Jáuregui J
Rev Clin Esp; 1997 Nov; 197 Suppl 3():44-7. PubMed ID: 9477690
[No Abstract] [Full Text] [Related]
16. The influence of psychotropic drugs on the levels of endogenous 2-phenylethylamine in rabbit brain.
Mosnaim AD; Inwang EE; Sabelli HC
Biol Psychiatry; 1974 Apr; 8(2):227-34. PubMed ID: 4842378
[No Abstract] [Full Text] [Related]
17. Current theories on the mode of action of antidepressant drugs.
Carlsson A
Adv Biochem Psychopharmacol; 1984; 39():213-21. PubMed ID: 6235723
[No Abstract] [Full Text] [Related]
18. Second-generation antidepressants.
Rudorfer MV; Golden RN; Potter WZ
Psychiatr Clin North Am; 1984 Sep; 7(3):519-34. PubMed ID: 6237317
[TBL] [Abstract][Full Text] [Related]
19. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.
Charney DS; Menkes DB; Heninger GR
Arch Gen Psychiatry; 1981 Oct; 38(10):1160-80. PubMed ID: 6271089
[TBL] [Abstract][Full Text] [Related]
20. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders.
Sulser F
J Clin Psychiatry; 1987 Mar; 48 Suppl():12-8. PubMed ID: 3029044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
